Dr. Parmjot Bains was appointed Managing Director and Chief Executive Officer of ImpediMed in January 2024. She is a high caliber healthcare executive with diverse experience including strategy, sales and marketing, commercial execution, and change management across the United States, Asia, Middle East, and Australia. Most recently, Dr. Bains was Pfizer’s Gulf Cluster Country Manager, responsible for setting commercial strategy, aligning team capabilities, driving private and public reimbursement, accelerating sales and marketing activities and key account management.
Dr. Bains managed a large team across six countries and six therapeutic areas including breast cancer, and successfully delivered significant growth against clear metrics and targets in various markets. Her other former roles include joint CEO and COO at Neuren Pharmaceuticals, CEO of Perseis Therapeutics, a Manager at McKinsey and Company. Dr Bains trained and practiced as a Medical Doctor in New Zealand and Australia.